Clinical Trial

Prospective Coronary Heart Disease Cohort

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-17.
Trial Details
NCT Number NCT05699629
Lead Sponsor Shandong First Medical University
Collaborators: Jinan Central Hospital, Shandong Provincial Hospital, The Second Affiliated Hospital of Shandong First Medical University, Qianfoshan Hospital
Conditions Coronary Heart Disease, Myocardial Infarction
Enrollment 50,000 participants
Start Date 2022-01-21
Primary Completion 2027-01-21 (estimated)
Study Completion 2027-01-21 (estimated)
Updated on ClinicalTrials.gov 2023-02-13